blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3423090

EP3423090 - NOVEL INFLUENZA ANTIGENS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.07.2024
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  28.07.2023
FormerGrant of patent is intended
Status updated on  27.03.2023
FormerExamination is in progress
Status updated on  21.02.2023
FormerGrant of patent is intended
Status updated on  15.11.2022
FormerExamination is in progress
Status updated on  24.04.2020
FormerRequest for examination was made
Status updated on  07.12.2018
FormerThe international publication has been made
Status updated on  08.09.2017
Formerunknown
Status updated on  13.03.2017
Most recent event   Tooltip05.07.2024No opposition filed within time limitpublished on 07.08.2024  [2024/32]
Applicant(s)For all designated states
GlaxoSmithKline Biologicals S.A.
Rue de l'Institut, 89
1330 Rixensart / BE
[2019/02]
Inventor(s)01 / VASSILEV, Ventzislav Bojidarov
GlaxoSmithKline Biologicals S.A.
rue de l'Institut 89
B-1330 Rixensart / BE
 [2019/02]
Representative(s)West, Heloise
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2019/02]
Application number, filing date17708482.902.03.2017
[2019/02]
WO2017EP54843
Priority number, dateGB2016000362502.03.2016         Original published format: GB 201603625
[2019/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017149054
Date:08.09.2017
Language:EN
[2017/36]
Type: A1 Application with search report 
No.:EP3423090
Date:09.01.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 08.09.2017 takes the place of the publication of the European patent application.
[2019/02]
Type: B1 Patent specification 
No.:EP3423090
Date:30.08.2023
Language:EN
[2023/35]
Search report(s)International search report - published on:EP08.09.2017
ClassificationIPC:A61K39/12, A61K39/145, C07K14/005
[2019/02]
CPC:
A61K39/145 (EP,US); A61K39/12 (EP,US); A61P31/16 (EP,US);
C07K14/005 (EP,US); C12N15/62 (EP,US); A61K2039/55511 (EP,US);
A61K2039/55577 (EP,US); C12N2760/16134 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/02]  
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:NEUARTIGE INFLUENZA-ANTIGENE[2019/02]
English:NOVEL INFLUENZA ANTIGENS[2019/02]
French:NOUVEAUX ANTIGÈNES DE LA GRIPPE[2019/02]
Entry into regional phase03.09.2018National basic fee paid 
03.09.2018Designation fee(s) paid 
03.09.2018Examination fee paid 
Examination procedure03.09.2018Amendment by applicant (claims and/or description)
03.09.2018Examination requested  [2019/02]
03.09.2018Date on which the examining division has become responsible
30.04.2020Despatch of a communication from the examining division (Time limit: M06)
04.11.2020Reply to a communication from the examining division
04.10.2022Cancellation of oral proceeding that was planned for 05.10.2022
05.10.2022Date of oral proceedings (cancelled)
16.11.2022Communication of intention to grant the patent
20.02.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
28.03.2023Communication of intention to grant the patent
24.07.2023Fee for grant paid
24.07.2023Fee for publishing/printing paid
24.07.2023Receipt of the translation of the claim(s)
Opposition(s)03.06.2024No opposition filed within time limit [2024/32]
Fees paidRenewal fee
08.03.2019Renewal fee patent year 03
10.03.2020Renewal fee patent year 04
09.03.2021Renewal fee patent year 05
23.03.2022Renewal fee patent year 06
21.03.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ30.08.2023
HR30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
[2024/23]
Former [2024/20]HR30.08.2023
PL30.08.2023
RS30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/10]HR30.08.2023
PL30.08.2023
RS30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/09]NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/08]NO30.11.2023
GR01.12.2023
Cited inInternational search[XY]  - FLORIAN KRAMMER ET AL, "A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates", PLOS ONE, (20120823), vol. 7, no. 8, doi:10.1371/journal.pone.0043603, page e43603, XP055181050 [X] 1,3-9,11,16,28 * page 2; figure 1B * [Y] 2,10,12-15,17-27,29,30

DOI:   http://dx.doi.org/10.1371/journal.pone.0043603
 [Y]  - SHUJUAN CUI ET AL, "Secretory expression of all 16 subtypes of the hemagglutinin 1 protein of influenza A virus in insect cells", JOURNAL OF VIROLOGICAL METHODS, ELSEVIER BV, NL, vol. 177, no. 2, doi:10.1016/J.JVIROMET.2011.07.014, ISSN 0166-0934, (20110725), pages 160 - 167, (20110730), XP028297787 [Y] 1-30 * page 161; figure 1 *

DOI:   http://dx.doi.org/10.1016/j.jviromet.2011.07.014
 [YD]  - R. HAI ET AL, "Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes", JOURNAL OF VIROLOGY, (20120307), vol. 86, no. 10, doi:10.1128/JVI.00137-12, ISSN 0022-538X, pages 5774 - 5781, XP055100236 [YD] 1-30 * figure 1 *

DOI:   http://dx.doi.org/10.1128/JVI.00137-12
ExaminationUS2008032921
    - TODD ARMSTRONG R ET AL, "The Transmembrane Domain of Influenza Hemagglutinin Exhibits a Stringent Length Requirement to Support the Hemifusion to Fusion Transition", vol. 151, no. 2, doi:10.1083/JCB.151.2.425, ISSN 0021-9525, (20001016), pages 425 - 437, THE JOURNAL OF CELL BIOLOGY, THE ROCKEFELLER UNIVERSITY PRESS, US, URL: http://jcb.rupress.org/content/151/2/425.full.pdf+html, XP008160422

DOI:   http://dx.doi.org/10.1083/jcb.151.2.425
by applicantWO9113281
 EP0516636
 EP0311863
 EP0382271
 WO9517210
 WO9633739
 US5650155
 US5667784
 WO9934850
 EP1092444
    - HAI ET AL., J. VIROL, (2012), vol. 86, no. 10, pages 5774 - 5781
    - WHITFORD ET AL., J. VIROL., (1989), vol. 63, pages 1393 - 1399
    - SAMBROOK ET AL., Molecular Cloning, A Laboratory Manual, COLD SPRING HARBOR PRESS, (1989), vol. 1-3
    - REMETA ET AL., BIOCHEM., (2002), vol. 41, pages 2044 - 2054
    - J.M. WOOD ET AL., J. M M BIOL. STAND., (1977), vol. 5, pages 237 - 247
    - J. M. WOOD ET AL., J. BIOL. STAND., (1981), vol. 9, pages 317 - 330
    - BEYER ET AL., CLIN DRUG INVEST, (1998), vol. 15, page 1
    - MEIER ET AL., J. MOL. BIOL., (2004), vol. 344, pages 1051 - 1069
    - GARGON ET AL., EXPERT. REV. VACCINES, (2012), vol. 11, pages 349 - 366
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.